Evidence map›Paper›PMID 29497453›Full record

ArticleImmunity & ageing : I & A2018

Gene and protein expression of

Monica Neri, Luigi Sansone, Luisa Pietrasanta, Aliaksei Kisialiou, Eloisa Cabano, Marina Martini, Matteo A Russo, Donatella Ugolini, Marco Tafani, Stefano Bonassi

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Immunity & ageing : I & A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Monica Neri1Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Val Cannuta, 247, 00166 Rome, Italy.ORCID 0000-0003-4796-3675
Luigi Sansone2Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome, Italy.
Luisa PietrasantaTerme di Genova, Genoa, Italy.
Aliaksei Kisialiou1Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Val Cannuta, 247, 00166 Rome, Italy.
Eloisa CabanoCasa di Cura Villa Montallegro, Genova, Italy.
Marina MartiniTerme di Genova, Genoa, Italy.
Matteo A Russo7Consortium MEBIC, San Raffaele University, Rome, Italy.
Donatella Ugolini8Department of Internal Medicine, University of Genoa, Genoa, Italy.
Marco Tafani2Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome, Italy.
Stefano Bonassi1Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Val Cannuta, 247, 00166 Rome, Italy.
Vita-Salute San Raffaele University · ITIRCCS Ospedale San Raffaele · ITIren Acqua Gas (Italy) · ITCasa di Cura Columbus · ITSan Raffaele University of Rome · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic rhinitis, pharyngitis and sinusitis are common health problems with a significant impact on public health, and are suspected to be influenced by ageing factors. Nasal inhalation with thermal water may be used to reduce symptoms, inflammation and drug intake. A pre-post clinical study was conducted in 183 consecutive adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis, to evaluate whether thermal water nasal inhalations could improve their symptoms, clinical signs and rhinomanometry measurements, and influence inflammatory biomarkers levels in nasal epithelial cells.

resultsParticipants profile revealed that they were aged on average (mean age and SD 60.6 ± 15.2 years, median 65, range 20-86, 86 aged ≤ 65 years (47%), 96 aged > 65 years (53%)) and extremely concerned about wellbeing. Older age was associated with better compliance to inhalation treatment. Total symptom and clinical evaluation scores were significantly ameliorated after treatment (

conclusionsThese results confirm the clinical impact of thermal water nasal inhalations on upper respiratory diseases both in adults and elders, and emphasize the role of genes activating tissue repair and inflammatory pathways. Future studies should evaluate CXCR4 as possible therapeutic target or response predictor in patients with chronic rhinitis, pharyngitis or sinusitis.

trial registrationCommunication to Italian Ministry of Health - ICPOM 000461. Registered 10/11/2014.

Indexed as

BalneologyClinical trialCXCR4Gene expression profilingInflammationRespiratory tract infections

Identifiers

PMID29497453
PMCPMC5828426
OpenAlexW2796251731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.